REG - Alliance Pharma PLC - Appointment of NED and SID

Alliance PharmaAnnouncement

01/02/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230201:nRSA4957Oa&default-theme=true

RNS Number : 4957O  Alliance Pharma PLC  01 February 2023

 For immediate release  1 February 2023

 

 

ALLIANCE PHARMA

("Alliance", "Company" or the "Group")

 

Appointment of Non-Executive Director and Senior Independent Director

 

Alliance Pharma plc (AIM: APH), the international healthcare group, is pleased
to announce the appointment of Martin Sutherland as a new independent
Non-Executive Director and Richard Jones, a Non-Executive Director since 2019,
as Senior Independent Director to strengthen the Board and support the
delivery of the Company's growth strategy.

 

Martin, who will join the Board with immediate effect, is a senior executive
with over 30 years' experience in global businesses.  He is currently a NED
at FTSE listed Forterra plc and Reliance acsn ltd. Forterra is a leading UK
manufacturer of essential clay and concrete building products. Martin joined
the Board of Forterra in 2017 and sits on the Nomination, Remuneration, Audit,
and Risk & Sustainability committees.  Reliance acsn ltd is a privately
held specialist cyber security business, a company which he joined in 2020 as
CEO and helped to drive a doubling of revenues in two years. Martin stepped
down as CEO to become NED in January 2023.

 

Martin was CEO of De La Rue plc between 2014 and 2019 and previously held
various roles at Detica plc, becoming Managing Director in 2008 on its
acquisition by BAE Systems plc.  Martin has a proven track record of
delivering growth through new product innovation, market diversification and
international expansion. We believe that Martin's experience will bring a new
perspective to complement the strong consumer healthcare knowledge already
present on the Board.

 

Following its annual review, the Board has decided to appoint Richard Jones,
current NED and Chair of Audit & Risk Committee, as Senior Independent
Director with immediate effect. Richard is CFO of Medica Group plc, the UK's
leading teleradiology provider, and has been on the Alliance Board since 1
January 2019.

 

David Cook, Chair of Alliance, said:

"I am delighted to welcome Martin Sutherland to the Board and look forward to
his contribution to support the delivery of our growth strategy.  Martin will
bring significant additional expertise from his experience as a company
director and in senior executive leadership roles.  The Board will also
benefit from his 30 years' experience in managing global businesses and
delivering growth.

 

"I am also pleased to appoint Richard Jones as our first Senior Independent
Director. Richard will help support and expand our stakeholder engagement
programme, building on his extensive experience in capital markets and
leveraging his strong networks with shareholders."

 

The following information is disclosed pursuant to Schedule Two, paragraph
(g), of the AIM Rules for Companies.

 

Mr Martin Conrad Sutherland, aged 54, has been a director of the following
companies during the five years preceding the date of this announcement:

 

 Current directorships   Directorships in the past five years:

 Forterra plc            De La Rue plc

 Reliance acsn Limited   19 Bennerley Road Limited

                         The International Currency Association Limited

 

Mr Sutherland does not hold any ordinary shares of 1 pence each in the
Company.

 

 

For further information:

 

 Alliance Pharma plc                                                       + 44 (0)1249 466966
 Cora McCallum, Head of Investor Relations & Corporate Communications      + 44 (0)1249 705168
 ir@allianceph.com (mailto:ir@allianceph.com)

 Buchanan                                                                  + 44 (0)20 7466 5000
 Mark Court / Hannah Ratcliff
 alliancepharma@buchanan.uk.com (mailto:alliancepharma@buchanan.uk.com)

 Numis Securities Limited                                                  + 44 (0)20 7260 1000
 Nominated Adviser: Freddie Barnfield / Duncan Monteith
 Corporate Broking: James Black

 Investec Bank plc                                                         + 44 (0)20 7597 5970
 Corporate Broking: Patrick Robb

 

 

About Alliance

 

Alliance Pharma plc (AIM: APH) is an international healthcare group. Our
purpose is to improve the lives of consumers and patients through making
available a range of clinically valuable healthcare products.

Our core focus is on the marketing of Consumer Healthcare brands, complemented
by a smaller Prescription Medicines business. In total, we hold marketing
rights to around 80 brands, with revenues generated from a mix of direct,
distributor and e-commerce sales.

Headquartered in the UK, the Group employs around 250 people based in
locations across Europe, North America, and the Asia Pacific region. By
outsourcing our manufacturing and logistics operations, we remain asset-light
and focused on maximising the value of our brands.

For more information on Alliance, please visit our
website: www.alliancepharmaceuticals.com
(http://www.alliancepharmaceuticals.com/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOADBGDBBGXDGXB